Skip to article
TeleHeadache
Headache Library

Nurtec ODT (Rimegepant): Migraine Treatment and Prevention

A silver blister strip of white tablets rests beside a blank planner, navy pen and teal glasses case.

Nurtec ODT (rimegepant) has two U.S. approved uses in adults: treating migraine attacks with or without aura, and preventing episodic migraine. The tablet dissolves in the mouth, but the treatment schedule depends on the purpose. A clinician should specify whether your plan is for attacks, prevention, or carefully coordinated use for both. Do not build that schedule yourself. [1]

One medicine, two different treatment goals

Rimegepant belongs to the gepant family and blocks the receptor for calcitonin gene-related peptide, or CGRP. [5] In an acute plan, the question is whether it helps an attack. In a preventive plan, the question is whether migraine becomes less burdensome over time.

The distinction affects how you use the prescription and what you track. A tablet kept for attacks is different from a tablet scheduled every other day. An unclear plan can create confusion about the next dose, the number used, and what to do when an attack occurs between scheduled doses.

Ask your clinician to write the purpose and schedule plainly. You can also read Medicines for Migraine Attacks vs. Prevention for an explanation of the broader treatment roles.

Understand the labeled schedule and limits

PurposeStandard labeled schedule
Acute migraine treatment75 mg as needed
Episodic migraine prevention75 mg every other day

Nurtec can be taken with or without food. The maximum is 75 mg in 24 hours, and safety of more than 18 doses in 30 days has not been established. Interactions may impose longer intervals. [1]

If your clinician coordinates both uses, ask how an attack dose affects the next scheduled dose and the monthly total. Do not add an extra dose to a preventive day because pain breaks through. Have a separate, agreed backup plan for situations when another Nurtec dose is unsuitable.

Put the schedule somewhere you can find during an attack. A calendar or simple medication log can be helpful when doses are spaced across days rather than taken every morning.

How to handle the dissolving tablet

With dry hands, peel back the blister foil rather than pushing the tablet through it. Place it on or under the tongue immediately after removal. It dissolves in saliva and does not require water. [5]

ODT stands for orally disintegrating tablet. This format may fit someone’s preferences, but the format alone does not establish better effectiveness or a faster clinical response than another treatment. Ask whether it addresses the practical problem you actually have.

If vomiting repeatedly prevents oral treatment, discuss that problem directly. Do not assume that a dissolving tablet removes every difficulty associated with nausea or vomiting.

What studies found for attacks and prevention

In a randomized trial treating a single migraine attack, 21% of participants receiving rimegepant ODT were pain-free at two hours, compared with 11% receiving placebo. Freedom from the most bothersome associated symptom occurred in 35% versus 27%, respectively. [3]

In a separate 12-week preventive trial using rimegepant every other day, monthly migraine days decreased by an average of 4.3 during weeks 9–12, compared with 3.5 with placebo. The difference was approximately 0.8 day per month. [4]

These are different outcomes from different studies. Neither predicts your personal result or proves superiority over another migraine medicine. Ask which outcome matters for your plan: sustained attack relief, fewer migraine days, improved function, or a combination of goals.

Check interactions before the next dose

Strong CYP3A4 inhibitors and strong or moderate CYP3A inducers should be avoided with Nurtec. With moderate CYP3A4 inhibitors or potent P-gp inhibitors, another dose must be avoided within 48 hours. [1]

Those terms describe how medicines affect drug handling in the body. You do not need to memorize the categories. You do need a current medication list and a pharmacist or prescriber who checks it against your plan.

Include supplements and temporary prescriptions. MedlinePlus flags St. John’s wort and advises discussing grapefruit. [5] Ask before starting, stopping, or changing a product rather than assuming a previously approved combination remains appropriate forever.

Severe liver impairment and end-stage kidney disease are reasons to avoid Nurtec. Tell your clinician about kidney or liver disease before prescribing. [1]

Side effects and important current warnings

Nausea can occur; preventive use can also cause abdominal pain or indigestion. [2] Report troublesome symptoms and describe whether they appeared after starting or changing the plan.

  • Allergic reactions: Stop Nurtec and seek emergency help for breathing difficulty or swelling involving the face, mouth, tongue, or throat. Serious reactions can occur days after a dose. [2]
  • Hypertension: New high blood pressure or worsening existing hypertension can occur. Contact your clinician about an increase and discuss monitoring. [2]
  • Raynaud’s phenomenon: Fingers or toes may become painful, numb, cold, or change color. Stop Nurtec and contact your clinician if symptoms develop; persistent symptoms require evaluation. [1] [2]

Do not take Nurtec if you have had an allergic reaction to rimegepant or its ingredients. [5] For sudden explosive headache, new weakness, speech trouble, or sudden vision loss, call 911 rather than waiting for a migraine medicine to work. [7]

Pregnancy and breastfeeding questions

Discuss pregnancy, pregnancy plans, or breastfeeding with your clinician, and contact them if pregnancy occurs during treatment. [5]

There are insufficient human data to establish pregnancy safety. [1]

A small human milk study found low transfer after a single rimegepant dose. It evaluated drug concentrations rather than proving safety outcomes in breastfed infants. [6]

Ask how those limitations affect your particular decision. A suitable plan should account for the parent’s migraine burden and the infant’s circumstances, with alternatives discussed when needed.

A practical checklist for follow-up

  • Confirm the purpose: Is this an attack plan, a preventive plan, or coordinated use?
  • Record doses: Include scheduled and attack doses in one log.
  • Describe benefit: Note headache days, relief, recurrence, and activities affected.
  • Report difficulties: Include side effects, missed doses, and access problems.
  • Bring the current list: Include every medicine and supplement.

A concrete account helps: “I followed the every-other-day schedule, but I was unsure what to do when an attack started the next morning.” Resolve that uncertainty before it leads to unplanned dosing. If relief or prevention remains inadequate, review the diagnosis and full plan with the clinician.

Frequently asked questions

Is Nurtec approved to prevent chronic migraine?

The U.S. preventive indication is for episodic migraine in adults. Chronic-migraine prevention requires a discussion of the appropriate options for that diagnosis. [2]

Can I use it for both attacks and prevention?

Both uses are approved, but combining them requires a clinician-defined schedule that respects dose limits, interactions, and your backup plan. Do not independently combine two sets of instructions.

Does dissolving in the mouth mean I need no water?

Yes, the ODT dissolves in saliva and can be swallowed without added liquid. Follow the blister-handling instructions and take it immediately after removal. [5]

More information and a clinical assessment

See the official Nurtec patient website and Drugs.com’s Nurtec ODT page for further resources.

Eligible adults 18 and older physically located in Florida with appropriate nonurgent headaches can request a TeleHeadache assessment. A clinician determines whether prescribing is appropriate. Medication costs are separate from clinical care; a requested prescription or insurance approval is not guaranteed.

Official medication information and further reading

Official Nurtec ODT website · Nurtec ODT on Drugs.com · Drugs.com

Use the current U.S. prescribing information and your own prescription instructions when discussing this medicine with your clinician or pharmacist.

Educational information supports a discussion with your clinician and does not replace individualized medical evaluation. Medication choice and prescribing require clinical review.

References

  1. Nurtec ODT U.S. prescribing information — DailyMed/Pfizer, revised April 2026. Accessed October 9, 2026.
  2. Nurtec ODT official patient website: Side Effects and Important Safety Information. Accessed October 9, 2026.
  3. Croop et al. Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for acute migraine treatment. Accessed October 9, 2026.
  4. Croop et al. Oral rimegepant for preventive treatment of migraine: a phase 2/3 randomized placebo-controlled trial. Accessed October 9, 2026.
  5. Rimegepant — MedlinePlus Drug Information. Accessed October 9, 2026.
  6. Baker et al. Human Milk and Plasma Pharmacokinetics of Single-Dose Rimegepant 75 mg in Healthy Lactating Women. Accessed October 9, 2026.
  7. CDC: Signs and Symptoms of Stroke. Accessed October 9, 2026.
Explore the Headache Library